// App-Quantinova.ai

4540 : Association of circulating tumor (ct)-DNA genomic alterations (GA) with outcomes in metastatic urothelial carcinoma (mUC).

Researchers

Presenter

  • Petros Grivas

Principal Investigators

  • Gregory Russell Pond

  • Rebecca J Nagy

  • Pedro C. Barata

  • Prateek Mendiratta

  • Dharmesh Gopalakrishnan

  • Alexandra Drakaki

  • Sumati Gupta

  • Neeraj Agarwal

  • Jue Wang

  • Bishoy Faltas

  • Ulka N. Vaishampayan

  • Gurudatta Naik

  • Bradley Alexander McGregor

  • Sumanta K. Pal

  • Lesli Ann Kiedrowski

  • Richard B. Lanman

  • Guru Sonpavde

Medical Centers

  • University of Washington, Seattle, WA

  • McMaster University, Hamilton, ON, Canada

  • Guardant Health, Rewdwood City, CA

  • Cleveland Clinic, Cleveland, OH

  • University of California, Los Angeles, Los Angeles, CA

  • University of Utah-Huntsman Cancer Institute, Salt Lake City, UT

  • Hunstman Cancer Institute of Utah, Salt Lake City, UT

  • University of Arizona Cancer Center at Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ

  • Division of Hematology & Medical Oncology, Meyer Cancer Center, Department of Urology, Weill Cornell Medical College & New York-Presbyterian Hospital, New York, NY

  • Karmanos Cancer Institute, Detroit, MI

  • University of Alabama at Birmingham, Birmingham, AL

  • David Grant Medical Center, Benicia, CA

  • City of Hope, Duarte, CA

  • Dana-Farber Cancer Institute, Boston, MA

Locations

  • United States

  • Canada

Companies

  • Guardant Health, Inc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved